Commentary on: “Multiple Single Cannulation Technique of Arteriovenous Fistula: A Randomised Controlled Trial”
One of the most important renal nursing procedures is the cannulation of a vascular access (VA), a procedure that is carried out on every single dialysis treatment. VA cannulation method is still a procedure that reflects local unit practices and the skill of the individual nurseArch Nephrol Ren Stud, 2021, Volume 1, Issue 1, p28-33 | DOI: 10.33696/nephrology.1.005
The Role of Direct Oral Anticoagulants in Advanced Chronic Kidney Disease – Questions and Future directions
With the advent of the direct oral anticoagulants (DOACs), patients requiring anticoagulation for common conditions such as atrial fibrillation and venous thromboembolism no longer need to worry about dietary restrictions or regular monitoring of the international normalized ratio which complicated warfarin treatment.Arch Nephrol Ren Stud, 2021, Volume 1, Issue 1, p16-20 | DOI: 10.33696/nephrology.1.003
Rituximab is a chimeric (20% rodent and 80% human) monoclonal antibody that binds to the CD20 antigen present on the cell surface and leads to depletion of mature B-cells [1,2]. It is the first approved monoclonal antibody to be used in the therapy of indolent B-cell non- Hodgkin’s lymphoma and chronic lymphocytic leukemiaArch Nephrol Ren Stud, 2021, Volume 1, Issue 1, p10-15 | DOI: 10.33696/nephrology.1.002
With readily available cross-sectional imaging, asymptomatic localized renal masses (LRMs) are often incidentally found. The standard management for LRM has been surgical resection, however, detection of masses that are benign or with low metastatic risk has led to interest in minimally invasive alternatives such as percutaneous thermal ablation (TA) or active surveillanceArch Nephrol Ren Stud, 2021, Volume 1, Issue 1, p1-9 | DOI: 10.33696/nephrology.1.001
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.